GENEDATA AG

History

Year	Detail
1997	Genedata was founded in Basel, Switzerland, as a company specializing in computational solutions for the life sciences industry.
2012	The company partnered with Life Technologies Corp. to create a streamlined ecosystem that empowered researchers in both academic and commercial settings to accelerate discovery and validation experiments.
2015	The company collaborated with Bayer Pharma AG to develop a new workflow management system to support the automation of the Cell Line Development (CLD) process for mammalian cells used to produce biopharmaceuticals.
2017	Genedata partnered with Crescendo Biologics to use the software to facilitate the swift identification and tracking of potential drug candidates with superior potency and developability.
2018	Bayer partnered with the company for the Genedata Selector platform, which supports Bayer’s global discovery process and data management efforts to digitalize crop science research and development.
2021	The company partnered with SCIEX, a provider of life science analytical technologies, to develop software solutions for the biopharmaceutical mass spectrometry market.
2021	The company collaborated with Egis Pharmaceuticals PLC, a European pharmaceutical company, to develop a precision medicine tool for rheumatoid arthritis.
2023	Genedata collaborated with the Astellas Institute for Regenerative Medicine (AIRM), a subsidiary of Astellas Pharma Inc., a global pharmaceutical company, to help confirm the biosafety of cell therapies using NGS-based assays within a validated environment.